A systematic review of vasopressor blood pressure targets in critically ill adults with hypotension;Une revue systématique des cibles de tension artérielle sous vasopresseurs chez des adultes gravement malades atteints d’hypotension

Canadian Journal of Anesthesia

Volumn 64, Issue 7, 2017, Pages 703-715

  Hylands, Mathieu ^a   Moller, Morten Hylander ^b   Asfar, Pierre ^c   Toma, Augustin ^d   Frenette, Anne Julie ^e   Beaudoin, Nicolas ^a   Belley Côté, Émilie ^a,d   D’Aragon, Frédérick ^a,f   Laake, Jon Henrik ^g   Siemieniuk, Reed Alexander ^d   Charbonney, Emmanuel ^e   Lauzier, François ^h   Kwong, Joey ⁱ   Rochwerg, Bram ^d   Vandvik, Per Olav ^j   Guyatt, Gordon ^d   Lamontagne, François ^a,f  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b Rigshospitalet   (Denmark)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d MCMASTER UNIVERSITY   (Canada)

^e Centre de Recherche Hopital Du Sacre Coeur de Montreal   (Canada)

^f CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^g ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^h Université Laval   (Canada)

ⁱ WUHAN UNIVERSITY   (China)

^j NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTENSIVE AGENT; VASOCONSTRICTOR AGENT;

AGE; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR MORTALITY; CHRONIC DISEASE; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; FLUID BALANCE; HEART ARRHYTHMIA; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPOTENSION; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; SUPRAVENTRICULAR CARDIAC ARRHYTHMIA; SURVIVOR; SYSTEMATIC REVIEW; ADULT; ARTERIAL PRESSURE; CRITICAL ILLNESS; DRUG EFFECTS;

ADULT; ARTERIAL PRESSURE; BLOOD PRESSURE; CRITICAL ILLNESS; HUMANS; HYPOTENSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VASOCONSTRICTOR AGENTS;

EID: 85018713131     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-017-0877-1     Document Type: Article

References (29)

1. Adhikari NK, Fowler RA, Bhagwanjee S, Rubenfeld GD. Critical care and the global burden of critical illness in adults. Lancet 2010; 376: 1339-46.
2. Lamontagne F, Cohen D, Herridge M. Understanding patient-centredness: contrasting expert versus patient perspectives on vasopressor therapy for shock. Intensive Care Med 2016. DOI:10.1007/s00134-016-4518-x.
3. Andreis DT, Singer M. Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum. Intensive Care Med 2016; 42: 1387-97.
4. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41: 580-637.
5. Schmittinger CA, Torgersen C, Luckner G, Schroder DC, Lorenz I, Dunser MW. Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study. Intensive Care Med 2012; 38: 950-8.
6. D’Aragon F, Belley-Cote EP, Meade MO, et al. Blood pressure targets for vasopressor therapy: a systematic review. Shock 2015; 43: 530-9.
7. Institute of Medicine; Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical practice guidelines we can trust. Washington, DC: National Academies Press; 2011.
8. Siemieniuk RA, Agoritsas T, Macdonald H, Guyatt GH, Brandt L, Vandvik PO. Introduction to BMJ rapid recommendations. BMJ 2016; 354: i5191.
9. Moher D, Liberati A, Tetzlaff J. Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009; 62: 1006-12.
10. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
11. Deeks JJ. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Stat Med 2002; 21: 1575-600.
12. ARISE Investigators; ANZICS Clinical Trials Group; Peake SL, Delaney A, Bailey M, et al. Goal-directed resuscitation for patients with early septic shock. The New England journal of medicine 2014; 371: 1496-506.
13. Bassler D, Briel M, Montori VM, et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA 2010; 303: 1180-7.
14. Guyatt G, Busse J. Modification of Cochrane Tool to assess risk of bias in randomized trials. 2016. Available from URL: http://distillercer.com/resources/ (accessed March 2017).
15. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-6.
16. Cochrane Handbook. Recommendations on testing for funnel plot asymmetry. Available from URL: http://handbook.cochrane.org/chapter_10/10_4_3_1_recommendations_on_testing_for_funnel_plot_asymmetry.htm (accessed March 2017).
17. Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines: 4. Rating the quality of evidence–study limitations (risk of bias). J Clin Epidemiol 2011; 64: 407-15.
18. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines 6. Rating the quality of evidence–imprecision. J Clin Epidemiol 2011; 64: 1283-93.
19. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 7. Rating the quality of evidence–inconsistency. J Clin Epidemiol 2011; 64: 1294-302.
20. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 8. Rating the quality of evidence–indirectness. J Clin Epidemiol 2011; 64: 1303-10.
21. Guyatt GH, Oxman AD, Montori V, et al. GRADE guidelines: 5. Rating the quality of evidence–publication bias. J Clin Epidemiol 2011; 64: 1277-82.
22. Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol 2008; 61: 763-9.
23. Asfar P, Meziani F, Hamel JF, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med 2014; 370: 1583-93.
24. Lamontagne F, Meade MO, Hebert PC, et al. Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial. Intensive Care Med 2016; 42: 542-50.
25. Alonso-Coello P, Oxman AD, Moberg J, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. BMJ 2016; 353: i2089.
26. Rochwerg B, Hylands M, Moller M, et al. CCCS-SSAI WikiRecs Clinical Practice Guideline: vasopressor blood pressure targets in critically ill adults with hypotension. Can J Anesth 2017; 64: this issue. DOI: 10.1007/s12630-017-0878-0
27. Rochwerg B, Hylands M, Moller M, et al. CCCS-SSAI WikiRecs Clinical Practice Guideline: vasopressors in early traumatic shock. Can J Anesth 2017; 64: this issue. DOI: 10.1007/s12630-017-0879-z
28. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358: 877-87.
29. Lamontagne F, Cook DJ, Meade MO, et al. Vasopressor use for severe hypotension-a multicentre prospective observational study. PloS One 2017; 12: e0167840.